Fragasso Financial Advisors Inc
Source: SEC Form 13F · as of Mar 2026Fragasso Financial Advisors Inc holds 16 biotech & pharma companies tracked by BioSniper, totaling $27.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
16
Total value held
$27.3M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 24,484 | $5.9M |
| LLYELI LILLY & Co | 4,566 | $4.2M |
| ABBVAbbVie Inc. | 20,341 | $4.2M |
| AMGNAMGEN INC | 11,730 | $4.0M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 7,362 | $2.1M |
| MRKMerck & Co., Inc. | 12,177 | $1.5M |
| ZTSZoetis Inc. | 10,636 | $1.3M |
| PMPhilip Morris International Inc | 4,896 | $785K |
| GMOptec International, Inc. | 8,850 | $650K |
| PFEPFIZER INC | 22,786 | $634K |
| ABTABBOTT LABORATORIES | 5,422 | $555K |
| GILDGILEAD SCIENCES, INC. | 2,834 | $397K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 895 | $389K |
| CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 1,522 | $256K |
| NVSNovartis AG | 1,540 | $235K |
| BMYBRISTOL MYERS SQUIBB CO | 3,656 | $217K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.